Theralase Technologies Inc. (TLTFF)

Market Cap	34.11M
Revenue (ttm)	718.24K
Net Income (ttm)	-2.96M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,602
Average Volume	54,021
Open	0.1416
Previous Close	0.1400
Day's Range	0.1366 - 0.1416
52-Week Range	0.0800 - 0.2700
Beta	1.14
RSI	45.80
Earnings Date	May 30, 2025

About Theralase Technologies

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Roger Dumoulin-White
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: TLTFF

Financial Performance

In 2024, Theralase Technologies's revenue was 1.03 million, a decrease of -3.45% compared to the previous year's 1.07 million. Losses were -4.26 million, -6.89% less than in 2023.

Financial numbers in CAD